Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARIA JAURRIETA

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner

NPI
1457704645
CMS profile
10747250
Location
MIAMI, FL

General Payments · PY2021–2024

$1,415.62

  • Reported across 26 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,169.02

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $700.00 1
Food and Beverage $469.02 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $14.74 1
PY2022 $98.71 3
PY2023 $133.15 5
PY2024 $1,169.02 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $700.00 05/05/2024 Consulting Fee Undisputed 01/23/2026 1105431867 CMS
AstraZeneca Pharmaceuticals LP $18.65 10/02/2024 Food and Beverage Undisputed 01/23/2026 1104315866 CMS
AstraZeneca Pharmaceuticals LP $23.79 12/04/2024 Food and Beverage Undisputed 01/23/2026 1105391143 CMS
Daiichi Sankyo Inc. $27.51 06/05/2024 Food and Beverage Undisputed 01/23/2026 1089437757 CMS
Janssen Biotech, Inc. $27.78 04/03/2024 Food and Beverage Undisputed 01/23/2026 1078447108 CMS
Lilly USA, LLC $19.62 05/09/2024 Food and Beverage Undisputed 01/23/2026 1135755211 CMS
Lilly USA, LLC $19.57 10/23/2024 Food and Beverage Undisputed 01/23/2026 1135834644 CMS
Merck Sharp & Dohme LLC $26.00 03/05/2024 Food and Beverage Undisputed 01/23/2026 1141800204 CMS
Merck Sharp & Dohme LLC $118.80 10/17/2024 Food and Beverage Undisputed 01/23/2026 1141800206 CMS
Novartis Pharmaceuticals Corporation $19.94 03/07/2024 Food and Beverage Undisputed 01/23/2026 1086967246 CMS
Novartis Pharmaceuticals Corporation $31.96 04/29/2024 Food and Beverage Undisputed 01/23/2026 1086967254 CMS
Novartis Pharmaceuticals Corporation $34.71 11/19/2024 Food and Beverage Undisputed 01/23/2026 1086967264 CMS
PFIZER INC. $16.28 04/11/2024 Food and Beverage Undisputed 01/23/2026 1131310927 CMS
PFIZER INC. $18.29 06/17/2024 Food and Beverage Undisputed 01/23/2026 1131712007 CMS
PUMA BIOTECHNOLOGY, INC. $18.45 08/28/2024 Food and Beverage Undisputed 01/23/2026 1113860681 CMS
Stemline Therapeutics Inc. $24.80 10/15/2024 Food and Beverage Undisputed 01/23/2026 1142969211 CMS
Tempus AI, Inc $22.87 12/18/2024 Food and Beverage Undisputed 01/23/2026 1150182786 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.